Spain At Appfire, we believe that great work happens when people get to choose how they work. After 20 years of creating software that empowers teams to break silos and collaborate seamlessly, weve learned that one
Senior AI/RAG Engineer (Document Intelligence) Location: Remote from Spain (an indefinite Spanish employment contract) Lea el resumen de esta oportunidad para comprender qué habilidades, incluidas las habilidades interpersonales relevantes y el dominio de paquetes de software,
Your Mission As a Tier 2 SOC Analyst , you will serve as a subject matter expert in our technology stack while optimizing security tools and detection workflows, mentoring junior analysts on complex investigation techniques, and
(Last day to apply: Sunday, September 20) About us Legit. Health deploys computer vision and artificial intelligence medical devices to enable lifesaving diagnosis and therapies for visible diseases. Our goal is to enable universal access to
Your Mission As a Tier 2 SOC Analyst , you will serve as a subject matter expert in our technology stack while optimizing security tools and detection workflows, mentoring junior analysts on complex investigation techniques, and
Your Mission Las cualificaciones, habilidades y toda la experiencia relevante necesaria para este puesto se pueden encontrar en la descripción completa a continuación. As a Security Analyst Level 1, you are the first line of defense
(Last day to apply: Sunday, September 20) About us Legit.Health deploys computer vision and artificial intelligence medical devices to enable lifesaving diagnosis and therapies for visible diseases. Our goal is to enable universal access to high-quality
Your Mission As a Security Analyst Level 1, you are the first line of defense within our 24x7 Managed Detection & Response (MDR) operations, part of the Cyber Fusion Center (CFC) / SOC. Your mission is
(Last day to apply: Sunday, September 20) About us Legit.Health deploys computer vision and artificial intelligence medical devices to enable lifesaving diagnosis and therapies for visible diseases. Our goal is to enable universal access to high-quality